ARTICLES
Suramin awakes?
HM Pinedo and RE van Rijswijk
JCO Jun 1 1992: 875–877. [PDF]
Meta-analyses need new publication standards
JW Andersen and D Harrington
JCO Jun 1 1992: 878–880. [PDF]
	Suramin: a novel growth factor antagonist with activity in hormone- refractory metastatic prostate cancer
	C Myers, M Cooper, C Stein, R LaRocca, MM Walther, G Weiss, P Choyke, N Dawson, S Steinberg, and MM Uhrich
	JCO Jun 1 1992: 881–889. [Abstract] [PDF]
	Does thoracic irradiation improve survival and local control in limited- stage small-cell carcinoma of the lung? A meta-analysis
	P Warde and D Payne
	JCO Jun 1 1992: 890–895. [Abstract] [PDF]
	Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project
	JCO Jun 1 1992: 896–903. [Abstract] [PDF]
	Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group
	JCO Jun 1 1992: 904–911. [Abstract] [PDF]
	Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience
	JD Hainsworth, DH Johnson, and FA Greco
	JCO Jun 1 1992: 912–922. [Abstract] [PDF]
	A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer
	D Feeny, W Furlong, RD Barr, GW Torrance, P Rosenbaum, and S Weitzman
	JCO Jun 1 1992: 923–928. [Abstract] [PDF]
	Comparison of high-dose and low-dose radiation with and without chemotherapy for children with Hodgkin's disease: an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania
	A Maity, JW Goldwein, B Lange, and GJ D'Angio
	JCO Jun 1 1992: 929–935. [Abstract] [PDF]
	Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation
	S Gulati, J Yahalom, L Acaba, L Reich, R Motzer, J Crown, M Toia, T Igarashi, R Lemoli, and E Hanninen
	JCO Jun 1 1992: 936–941. [Abstract] [PDF]
	Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation
	DJ Weisdorf, JW Andersen, JH Glick, and MM Oken
	JCO Jun 1 1992: 942–947. [Abstract] [PDF]
	Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia
	EH Rubin, JW Andersen, DT Berg, CA Schiffer, RJ Mayer, and RM Stone
	JCO Jun 1 1992: 948–953. [Abstract] [PDF]
	Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effect of treatment with interferon-alpha
	R Foa, A Guarini, P Francia di Celle, L Trentin, A Gillio Tos, G Bellone, A Carbone, C Attisano, M Massaia, and D Raspadori
	JCO Jun 1 1992: 954–959. [Abstract] [PDF]
	Prolonged continuous intravenous infusion interleukin-2 and lymphokine- activated killer-cell therapy for metastatic renal cell carcinoma
	JA Thompson, KL Shulman, MC Benyunes, CG Lindgren, C Collins, PH Lange, WH Bush, Jr, LA Benz, and A Fefer
	JCO Jun 1 1992: 960–968. [Abstract] [PDF]
	Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer
	R Henriksson, L Franzen, and B Littbrand
	JCO Jun 1 1992: 969–975. [Abstract] [PDF]
	Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute
	AS Lichter, ME Lippman, DN Danforth, Jr, T d'Angelo, SM Steinberg, E deMoss, HD MacDonald, CM Reichert, M Merino, and SM Swain
	JCO Jun 1 1992: 976–983. [Abstract] [PDF]
	Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research
	G Cocconi, G Bisagni, G Ceci, M Bacchi, C Boni, M Brugia, A Carpi, F Di Costanzo, V Franciosi, and S Gori
	JCO Jun 1 1992: 984–989. [Abstract] [PDF]
	Identification of estrogenic tamoxifen metabolite(s) in tamoxifen- resistant human breast tumors
	VJ Wiebe, CK Osborne, WL McGuire, and MW DeGregorio
	JCO Jun 1 1992: 990–994. [Abstract] [PDF]
	Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response
	LJ Ayash, JE Wright, O Tretyakov, R Gonin, A Elias, C Wheeler, JP Eder, A Rosowsky, K Antman, and E Frei, 3d
	JCO Jun 1 1992: 995–1000. [Abstract] [PDF]
	Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies
	VW Rusch, D Niedzwiecki, Y Tao, C Menendez-Botet, A Dnistrian, D Kelsen, L Saltz, and M Markman
	JCO Jun 1 1992: 1001–1006. [Abstract] [PDF]
	Patient compliance with oral chemotherapy as assessed by a novel electronic technique
	CR Lee, PW Nicholson, RL Souhami, and AA Deshmukh
	JCO Jun 1 1992: 1007–1013. [Abstract] [PDF]
	Inflammatory breast cancer: a review
	IA Jaiyesimi, AU Buzdar, and G Hortobagyi
	JCO Jun 1 1992: 1014–1024. [Abstract] [PDF]
Breast cancer: evaluating trial results
MH Cohen
JCO Jun 1 1992: 1025–1026. [PDF]

SPECIAL DEPARTMENTS
ERRATUM
	Interleukin-2 and Lymphokine-Activated Killer Cells in 15 Children With Advanced Metastatic Neuroblastoma
	S. Negrier, J. Michon, D. Floret, E. Bouffet, J.C. Gentet, I. Philip, P. Cochat, D. Stamm, J. Costil, M. Gaspard, G. Andreu, P. Palmer, C.R. Franks, J.M. Zucker, J.L. Bernard, W.H. Fridman, M. Favrot, and T. Philip
	JCO Jun 1 1992: 1026. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.